Cargando…
In-depth proteomic characterization of Schistosoma haematobium: Towards the development of new tools for elimination
BACKGROUND: Schistosomiasis is a neglected disease affecting hundreds of millions worldwide. Of the three main species affecting humans, Schistosoma haematobium is the most common, and is the leading cause of urogenital schistosomiasis. S. haematobium infection can cause different urogenital clinica...
Autores principales: | Sotillo, Javier, Pearson, Mark S., Becker, Luke, Mekonnen, Gebeyaw G., Amoah, Abena S., van Dam, Govert, Corstjens, Paul L. A. M., Murray, Janice, Mduluza, Takafira, Mutapi, Francisca, Loukas, Alex |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6538189/ https://www.ncbi.nlm.nih.gov/pubmed/31091291 http://dx.doi.org/10.1371/journal.pntd.0007362 |
Ejemplares similares
-
Characterisation of tetraspanins from Schistosoma haematobium and evaluation of their potential as novel diagnostic markers
por: Mekonnen, Gebeyaw G., et al.
Publicado: (2022) -
Regulatory and Activated T Cells in Human Schistosoma haematobium Infections
por: Nausch, Norman, et al.
Publicado: (2011) -
Schistosoma haematobium Extracellular Vesicle Proteins Confer Protection in a Heterologous Model of Schistosomiasis
por: Mekonnen, Gebeyaw G., et al.
Publicado: (2020) -
Association between Micronutrients (Vitamin A, D, Iron) and Schistosome-Specific Cytokine Responses in Zimbabweans Exposed to Schistosoma haematobium
por: Reilly, Liam, et al.
Publicado: (2012) -
Predicted Impact of Mass Drug Administration on the Development of Protective Immunity against Schistosoma haematobium
por: Mitchell, Kate M., et al.
Publicado: (2014)